Search
Login Anonymous

Pertuzumab #
Find similar titles

Structured data

Drug Class: HER dimerization inhibitors
URL: http://en.wikipedia.org/wiki/Pertuzumab

Pertuzumab (also called 2C4, trade name Perjeta) is a Monoclonal antibody marketed by Genentech for the treatment of HER2+ Breast cancer, in combination with Trastuzumab and Docetaxel.

By binding to HER2, it inhibits the dimerization of HER2 with other HER receptors, which is hypothesized to result in slowed tumor growth.

Incoming Links #

Related Medical Scholarly Articles (MedicalScholarlyArticle 0) #

Comprehensive molecular portraits of human breast tumours

Suggested Pages #

0.038 METABRIC
0.025 May 10
0.025 BRCA2
0.025 May 13
0.025 강석기
0.025 The Cancer Genome Atlas
0.025 2014
0.025 2016
0.025 BRCA1
0.025 April 29
More suggestions...